Publicacions en què col·labora amb A. Suárez Gauthier (16)

2024

  1. Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach

    Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326

2014

  1. Accurate identification of ALK positive lung carcinoma patients: Novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

    PLoS ONE, Vol. 9, Núm. 9

2013

  1. Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer

    International Journal of Cancer, Vol. 133, Núm. 4, pp. 898-907

  2. The ALK translocation in advanced non-small-cell lung carcinomas: Preapproval testing experience at a single cancer centre

    Histopathology, Vol. 62, Núm. 4, pp. 609-616

2012

  1. A comparison of EGFR mutation testing methods in lung carcinoma: Direct sequencing, real-time PCR and immunohistochemistry

    PLoS ONE, Vol. 7, Núm. 8

  2. A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

    British Journal of Cancer, Vol. 107, Núm. 2, pp. 345-351

2011

  1. Composite anatomical-clinical-molecular prognostic model in nonsmall cell lung cancer

    European Respiratory Journal, Vol. 37, Núm. 1, pp. 136-142

  2. Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: A comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method

    Histopathology, Vol. 59, Núm. 1, pp. 8-17

2010

  1. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: A morphology-based approach in colorectal carcinoma

    Journal of Molecular Diagnostics, Vol. 12, Núm. 3, pp. 292-299

  2. The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung

    PLoS ONE, Vol. 5, Núm. 8

2009

  1. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development

    Molecular Cancer Therapeutics, Vol. 8, Núm. 2, pp. 310-314

2008

  1. Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer

    Molecular Cancer Therapeutics, Vol. 7, Núm. 10, pp. 3275-3284

  2. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

    Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356

2007

  1. Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas

    Lung Cancer, Vol. 58, Núm. 3, pp. 303-309

  2. Myxoinflammatory fibroblastic sarcoma: Report of a case with fine needle aspiration cytology

    Acta Cytologica, Vol. 51, Núm. 2, pp. 231-234

  3. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas

    Human Pathology, Vol. 38, Núm. 9, pp. 1351-1360